Robert Roessle Klinik Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
1999
NCT00004150
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now